New client programme to be supported from OXB’s FDA-approved, commercial scale viral vector manufacturing facility in Durham, North Carolina, ...
As gene-modified cell therapy programs move into later-stage development, maintaining continuity across plasmid design and ...
A longevity gene therapy targeting the molecular mechanism behind why some people live to 100 has maintained its early benefits three months after dosing aged beagles — and the Vancouver firm whose ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results